Antinociceptive and anti-exudative synergism between dexketoprofen and tramadol in a model of inflammatory pain in mice

Fundamental and Clinical Pharmacology

Volumn 26, Issue 3, 2012, Pages 373-382

  Miranda, Hugo F ^a   Romero, Maria Asunción ^b   Puig, Margarita M ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Anti extravasation; Antinociception; Chronic musculoskeletal pain; Dexketoprofen; Synergy; Tramadol

Indexed keywords

DEXKETOPROFEN; FREUND ADJUVANT; TRAMADOL;

ACUTE DISEASE; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; CHRONIC INFLAMMATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENTIATION; EXTRAVASATION; HOT PLATE TEST; INFLAMMATION; MALE; MOUSE; MUSCULOSKELETAL PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG SYNERGISM; INFLAMMATION; KETOPROFEN; MALE; MICE; PAIN; PAIN MEASUREMENT; TRAMADOL; TROMETHAMINE;

EID: 84860233474     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00922.x     Document Type: Article

References (36)

1. Curatolo M., Sveticic G. Drug combination in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Pract. Res. Clin. Anaesthesiol. (2002) 16 507-519.
2. Miranda H.F., Puig M.M., Romero M.A., Prieto J.C. Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice, Fund. Clin. Pharmacol. (2009) 23 81-88.
3. Larson A.A., Brown D.R., El-Atrash S., Walser M.M. Pain threshold changes in adjuvant-induced inflammation: a possible model of chronic pain in the mouse. Pharmacol. Biochem. Behav. (1986) 24 49-53.
4. Fernandez-Dueñas V., Pol O., Garcia-Nogales P., Hernandez L., Planas E., Puig M.M. Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation. J. Pharmacol. Exp. Ther. (2007) 322 360-368.
5. Planas M.E., Rodriguez L., Sanchez S., Pol O., Puig M.M. Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain (1995) 60 67-71.
6. Melendez L., Lastra A., Hidalgo A., Baamonde A. Unilateral hot plate: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J. Neurosci. Methods (2002) 113 91-97.
7. Menéndez L., Lastra A., Fresno M.F. et al. Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer. Brain Res. (2003) 969 102-109.
8. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of morphine, meperidine and brain item stimulation in rats and cats. Pain (1997) 4 161-174.
9. Smith S.B., Crager S.E., Mogil J.S. Paclitaxel-induced neuropathic hypersensitivity in mice: response in 10 inbred mouse strains. Life Sci. (2004) 74 2593-2604.
10. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain (1994) 59 369-376.
11. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain (2000) 87 149-158.
12. Emanueli C., Grady E.F., Madeddu P. et al. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension (1998) 31 1299-1304.
13. Miranda H.F., Puig M.M., Prieto J.C., Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain (2006) 121 22-28.
14. Miranda H.F., Puig M.M., Dursteler C., Prieto J.C., Pinardi G. Dexketoprofen induced antinociception in animal models of acute pain: synergy with morphine and paracetamol. Neuropharmacology (2007) 52 291-296.
15. Tallarida R.J. Drugs synergism and dose-effect data analysis, Chapman & Hall/CRC Press, Boca Raton, FL, 2000, pp. 59-63.
16. Perrot S., Guilbaud G., Kayser V. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation. Anesthesiology (2001) 94 870-875.
17. Planas E., Sánchez S., Rodriguez L., Pol O., Puig M.M. Antinociceptive/anti-edema effects of liposomal morphine during acute inflammation of the rat paw. Pharmacology (2000) 60 121-127.
18. Mazario J., Gaitan G., Herrero J.F. Cyclooxygenase-1 vs. Cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology (2001) 40 937-946.
19. Cain D.M., Khasabov S.G., Simone D.A. Response properties of mechanoreceptors and nociceptors in mouse glabrous skin: an in vivo study. J. Neurophysiol. (2001) 85 1561-1574.
20. Foulkes T., Wood J.N. Mechanisms of cold pain. Channels (2007) 1 154-160.
21. Hu H., Tian J., Zhu Y. et al. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs. Pflugers Arch. (2010) 459 579-592.
22. Leung G.P., Cheung K.H., Leung C.T., Tsang M.W., Wong P.Y. Regulation of epididymal principal cell functions by basal cells: role of transient receptor potential (Trp) proteins and cyclooxygenase-1 (COX-1). Mol. Cell. Endocrinol. (2004) 216 5-13.
23. Zegpi C., Gonzalez C., Pinardi G., Miranda H.F. The effect of opioid antagonists on synergism between dexketoprofen and tramadol. Pharmacol. Res. (2009) 60 291-295.
24. Nagy J.A., Benjamin L., Zeng H., Dvorak A.M., Dvorak H.F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis (2008) 11 109-119.
25. Cadet P., Mantione K.J., Stefano G.B. Molecular identification and functional expression of μ3, a novel alternatively spliced variant of the human μ opiate receptor gene. J. Immunol. (2003) 170 5118-5123.
26. Romero A., Planas E., Poveda R., Sánchez S., Pol O., Puig M.M. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. Eur. J. Pharmacol. (2005) 511 207-217.
27. Burian M., Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol. Ther. (2005) 107 139-154.
28. Barrera N.P., Morales B., Torres S., Villalón M. Principles: mechanisms and modeling of synergism in cellular responses. Trends Pharmacol. Sci. (2005) 26 526-532.
29. Minami K., Uezon Y., Ueta Y. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. Pharmacol. Sci. (2007) 103 253-260.
30. Miranda H.F., Sierralta F., Pinardi G. An isobolographic analysis of the adrenergic modulation of diclofenac antinociception. Anesth. Analg. (2001) 93 430-435.
31. Pinardi G., Sierralta F., Miranda H.F. Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems. Inflammation (2001) 25 233-239.
32. Jain N.K., Kulkarni S.K., Singh A. Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects. Life Sci. (2002) 70 2857-2869.
33. Taiwo Y.O., Levine J.D. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J. Neurosci. (1988) 8 1346-1349.
34. Mattia C., Coluzzi F. Tramadol. Focus on musculoskeletal and neuropathic pain. Minerva Anestesiol. (2005) 71 565-584.
35. Schug S.A. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther. Clin. Risk Manag. (2007) 3 717-723.
36. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. (2006) 58 621-681.